UniProt ID | SODE_HUMAN | |
---|---|---|
UniProt AC | P08294 | |
Protein Name | Extracellular superoxide dismutase [Cu-Zn] | |
Gene Name | SOD3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 240 | |
Subcellular Localization | Secreted, extracellular space. 99% of EC-SOD is anchored to heparan sulfate proteoglycans in the tissue interstitium, and 1% is located in the vasculature in equilibrium between the plasma and the endothelium. | |
Protein Description | Protect the extracellular space from toxic effect of reactive oxygen intermediates by converting superoxide radicals into hydrogen peroxide and oxygen.. | |
Protein Sequence | MLALLCSCLLLAAGASDAWTGEDSAEPNSDSAEWIRDMYAKVTEIWQEVMQRRDDDGALHAACQVQPSATLDAAQPRVTGVVLFRQLAPRAKLDAFFALEGFPTEPNSSSRAIHVHQFGDLSQGCESTGPHYNPLAVPHPQHPGDFGNFAVRDGSLWRYRAGLAASLAGPHSIVGRAVVVHAGEDDLGRGGNQASVENGNAGRRLACCVVGVCGPGLWERQAREHSERKKRRRESECKAA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
24 | Phosphorylation | DAWTGEDSAEPNSDS CCCCCCCCCCCCCCH | 30.17 | 26657352 | |
29 | Phosphorylation | EDSAEPNSDSAEWIR CCCCCCCCCHHHHHH | 43.59 | 26657352 | |
29 | O-linked_Glycosylation | EDSAEPNSDSAEWIR CCCCCCCCCHHHHHH | 43.59 | OGP | |
31 | Phosphorylation | SAEPNSDSAEWIRDM CCCCCCCHHHHHHHH | 28.10 | 26657352 | |
107 | N-linked_Glycosylation | EGFPTEPNSSSRAIH CCCCCCCCCCCCEEE | 48.57 | 16335952 | |
155 | Phosphorylation | NFAVRDGSLWRYRAG CEEEECCCCEEECHH | 29.10 | 24719451 | |
159 | Phosphorylation | RDGSLWRYRAGLAAS ECCCCEEECHHHHHH | 8.01 | 22617229 | |
166 | Phosphorylation | YRAGLAASLAGPHSI ECHHHHHHHCCCCCE | 17.10 | 22617229 | |
172 | Phosphorylation | ASLAGPHSIVGRAVV HHHCCCCCEECEEEE | 23.31 | 22617229 | |
195 | Phosphorylation | GRGGNQASVENGNAG CCCCCCHHHHCCCHH | 21.87 | 29759185 | |
229 | Glycation | AREHSERKKRRRESE HHHHHHHHHHHHHHH | 46.72 | - | |
229 | N-linked_Glycosylation | AREHSERKKRRRESE HHHHHHHHHHHHHHH | 46.72 | 1505778 | |
230 | Glycation | REHSERKKRRRESEC HHHHHHHHHHHHHHH | 58.31 | - | |
230 | N-linked_Glycosylation | REHSERKKRRRESEC HHHHHHHHHHHHHHH | 58.31 | 1505778 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SODE_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SODE_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SODE_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of SODE_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"The site of nonenzymic glycation of human extracellular-superoxidedismutase in vitro."; Adachi T., Ohta H., Hayashi K., Hirano K., Marklund S.L.; Free Radic. Biol. Med. 13:205-210(1992). Cited for: GLYCATION AT LYS-229 AND LYS-230. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-107, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-107, AND MASSSPECTROMETRY. |